x_label	specimen_descriptor_fill	box_sample_count	Gene_Ensembl_ID	Gene_symbol	PMTL	Dataset	Disease	GTEx_tissue_subgroup	EFO	MONDO	GTEx_tissue_subgroup_UBERON	TPM_mean	TPM_sd	TPM_min	TPM_25th_percentile	TPM_median	TPM_75th_percentile	TPM_max
Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)	Pediatric Primary and Relapse Tumors	613	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Acute Lymphoblastic Leukemia		EFO_0000220	MONDO_0004967		3.96	4.13	0	1.36	2.69	4.87	33.49
Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)	Pediatric Primary and Relapse Tumors	210	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		4.73	5.43	0	1.06	3.12	6.32	36.98
Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 58)	Pediatric Primary and Relapse Tumors	58	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Adamantinomatous Craniopharyngioma		EFO_1000069	MONDO_0002787		1.15	2.14	0.08	0.37	0.56	1.21	14.83
Atypical choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Atypical choroid plexus papilloma		EFO_1000177	MONDO_0002684		1.52	1.25	0.25	0.91	1.57	2.16	2.74
Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)	Pediatric Primary and Relapse Tumors	59	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Atypical Teratoid Rhabdoid Tumor		EFO_1002008	MONDO_0020560		3.46	5.38	0	1.34	2.14	2.88	35.71
Central neurocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Central neurocytoma		EFO_1000856	MONDO_0019134		1.2	1.81	0.09	0.15	0.21	1.75	3.29
Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)	Pediatric Primary and Relapse Tumors	8	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Chordoma		MONDO_0008978	MONDO_0008978		0.91	0.74	0	0.41	0.74	1.44	1.98
Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)	Pediatric Primary and Relapse Tumors	15	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Choroid plexus carcinoma		MONDO_0016718	MONDO_0016718		11.14	24.05	0.14	0.56	0.99	7.91	90.3
CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)	Pediatric Primary and Relapse Tumors	20	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	CNS Embryonal tumor		EFO_0005784	MONDO_0018843		8.8	16.47	0.13	0.68	1.66	7.87	64.08
CNS neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	CNS neuroblastoma		EFO_0000621	MONDO_0006130		8.48	10.55	1.52	2.42	3.31	11.96	20.62
Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)	Pediatric Primary and Relapse Tumors	16	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Craniopharyngioma		EFO_1000209	MONDO_0002787		0.38	0.34	0.06	0.16	0.26	0.48	1.39
Desmoplastic infantile astrocytoma and ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Desmoplastic infantile astrocytoma and ganglioglioma		MONDO_0022963	MONDO_0016731		0.4	0.5	0.08	0.11	0.14	0.55	0.97
Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 28)	Pediatric Primary and Relapse Tumors	28	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse hemispheric glioma		MONDO_0016680	MONDO_0016680		4.12	7.05	0.15	1	2.67	4.21	38.48
Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)	Pediatric Primary and Relapse Tumors	10	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse intrinsic pontine glioma		EFO_1000026	MONDO_0006033		1.16	0.98	0.1	0.35	1.03	1.66	2.74
Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)	Pediatric Primary and Relapse Tumors	164	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse midline glioma		EFO_1000026	MONDO_0006033		3.48	6.11	0	0.52	1.24	2.98	35.27
Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)	Pediatric Primary and Relapse Tumors	39	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Dysembryoplastic neuroepithelial tumor		EFO_0005551	MONDO_0005505		0.45	1.06	0.01	0.11	0.16	0.34	6.46
Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)	Pediatric Primary and Relapse Tumors	5	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Embryonal tumor with multilayer rosettes		MONDO_0016715	MONDO_0016715		5.52	4.4	1.19	3.83	4.34	5.32	12.9
Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)	Pediatric Primary and Relapse Tumors	163	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ependymoma		EFO_1000028	MONDO_0016698		0.83	1.23	0.01	0.16	0.43	0.97	8.92
Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)	Pediatric Primary and Relapse Tumors	13	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ewing sarcoma		EFO_0000174	MONDO_0012817		1.5	0.91	0.25	0.84	1.2	2.08	3.53
Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)	Pediatric Primary and Relapse Tumors	80	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ganglioglioma		EFO_0003094	MONDO_0016733		0.43	0.94	0.02	0.14	0.26	0.39	7.95
Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 45)	Pediatric Primary and Relapse Tumors	45	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		2.53	2.72	0.08	0.64	1.23	3.55	11.91
Ganglioneuroma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 4)	Pediatric Primary and Relapse Tumors	4	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Ganglioneuroma		EFO_0000500	MONDO_0005033		0.26	0.23	0.09	0.1	0.2	0.36	0.58
Ganglioneuroma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ganglioneuroma		EFO_0000500	MONDO_0005033		0.16	0.11	0.09	0.1	0.1	0.2	0.29
Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)	Pediatric Primary and Relapse Tumors	10	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Germinoma		MONDO_0020580	MONDO_0020580		4.54	6.06	0.55	1.21	2.9	4.01	20.79
Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)	Pediatric Primary and Relapse Tumors	24	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Glial-neuronal tumor		MONDO_0016729	MONDO_0016729		1.13	2.04	0.02	0.13	0.32	0.84	8.16
Glioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)	Pediatric Primary and Relapse Tumors	5	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Glioblastoma		MONDO_0018177	MONDO_0018177		1.99	2.29	0.06	0.38	1.27	2.54	5.72
Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)	Pediatric Primary and Relapse Tumors	5	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Hemangioblastoma		MONDO_0016748	MONDO_0016748		0.3	0.24	0.04	0.16	0.29	0.33	0.68
High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 175)	Pediatric Primary and Relapse Tumors	175	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	High-grade glioma		MONDO_0100342	MONDO_0100342		3.95	7.66	0.01	0.52	1.52	3.73	57.89
Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)	Pediatric Primary and Relapse Tumors	10	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Infant-type hemispheric glioma		EFO_0005543	MONDO_0014695		0.61	0.47	0.15	0.27	0.33	1.08	1.28
Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 412)	Pediatric Primary and Relapse Tumors	412	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Low-grade glioma		MONDO_0021637	MONDO_0021637		0.47	0.85	0	0.14	0.24	0.45	7.69
Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)	Pediatric Primary and Relapse Tumors	6	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Malignant peripheral nerve sheath tumor		EFO_0000760	MONDO_0017827		1.45	1.12	0.33	0.61	1.36	1.74	3.39
Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)	Pediatric Primary and Relapse Tumors	237	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Medulloblastoma		EFO_0002939	MONDO_0007959		4.44	10.54	0.07	1.19	1.81	3.28	115.46
Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)	Pediatric Primary and Relapse Tumors	42	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Meningioma		MONDO_0016642	MONDO_0016642		0.77	2.5	0	0.21	0.32	0.52	16.37
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)	Pediatric Primary and Relapse Tumors	318	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		3.91	3.67	0.06	1.85	3.24	5.21	47.65
Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)	Pediatric Primary and Relapse Tumors	7	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Neuroblastoma		EFO_0000621	MONDO_0005072		1.61	1.36	0.06	0.3	2.23	2.48	3.41
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)	Pediatric Primary and Relapse Tumors	137	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		3.94	3.22	0.1	1.54	3.09	5.39	21.06
Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)	Pediatric Primary and Relapse Tumors	20	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Neurofibroma/Plexiform		EFO_0000658	MONDO_0003304		0.34	0.41	0.02	0.11	0.2	0.36	1.67
Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)	Pediatric Primary and Relapse Tumors	5	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Non-germinomatous germ cell tumor		MONDO_0020580	MONDO_0020580		3.48	4.2	0.13	0.24	0.88	8.05	8.09
Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 62)	Pediatric Primary and Relapse Tumors	62	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Oligodendroglioma		EFO_0000632	MONDO_0016695		0.47	0.65	0.01	0.16	0.26	0.53	4.19
Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)	Pediatric Primary and Relapse Tumors	10	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Pilocytic astrocytoma		MONDO_0016691	MONDO_0016691		0.75	1.11	0.06	0.09	0.14	1.11	3.53
Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)	Pediatric Primary and Relapse Tumors	14	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Pineoblastoma		EFO_1000475	MONDO_0016722		4.73	7.44	0.03	0.89	1.59	4.06	25.01
Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)	Pediatric Primary and Relapse Tumors	16	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Sarcoma		EFO_0000691	MONDO_0005089		1.17	1	0.08	0.57	0.96	1.58	4.16
Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)	Pediatric Primary and Relapse Tumors	27	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Schwannoma		EFO_0000693	MONDO_0002546		0.48	0.36	0.04	0.2	0.46	0.6	1.73
Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)	Pediatric Primary and Relapse Tumors	14	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Subependymal Giant Cell Astrocytoma		MONDO_0016693	MONDO_0016693		0.51	0.31	0.12	0.32	0.45	0.69	1.31
Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)	Pediatric Primary and Relapse Tumors	9	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Teratoma		MONDO_0002601	MONDO_0002601		0.69	0.82	0.01	0.16	0.37	0.83	2.29
Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)	Pediatric Primary and Relapse Tumors	129	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Wilms tumor		MONDO_0006058	MONDO_0006058		5.73	3.78	0.36	2.6	4.92	7.68	20.45
